Literature DB >> 31773488

Executive functions predict fracture risk in postmenopausal women assessed for osteoporosis.

Antonino Catalano1,2, Alberto Sardella3, Federica Bellone3,4, Carmen Giulia Lasco3, Gabriella Martino3, Nunziata Morabito3,4.   

Abstract

BACKGROUND: Cognitive impairment and muscle strength have been associated with bone fragility. However, the potential predictive role of executive functions on fracture risk has been poorly investigated. AIM: We intended to explore the association between executive functions, psychological distress and physical performance with fracture risk in postmenopausal women.
METHODS: Cognitive tests explicating executive functions (i.e., Trial Making Test-B, Digit Span Backward, Digit Span Forward) and questionnaires assessing psychological distress (i.e., Back Depression Inventory and Hamilton Anxiety Scale) were administered. Physical performance was explored through the Short Physical Performance Battery and handgrip strength. The 10-year probability of major and hip fractures was assessed by Fracture Risk Assessment tool (FRAX); the bone mineral density (BMD) was evaluated by Dual-Energy X-ray Absorptiometry.
RESULTS: 60 women (mean age 66 ± 7.99 yr.) were recruited. The FRAX score for major fractures was significantly associated with Trial Making Test B score (r = - 0.25) and with Digit Span Backward (r = - 0.34); the FRAX score for hip fracture was associated with handgrip strength (r = - 0.39, p = 0.002). BMD was significantly associated with Digit Span Backward (r = - 0.32) and with depression (r = - 0.33). After several adjustments, the multiple regression analysis showed that BMI (ß = 0.09, SE 0.03, p = 0.013), Beck Depression Inventory score (ß = - 0.09, SE 0.06, p = 0.04) and Digit Span Backward score (ß = 0.55, SE 0.17, p = 0.002) were independently predictive of lumbar BMD.
CONCLUSIONS: Verbal working memory, as assessed by Digit Span Test, and psychological features were associated with BMD and could contribute to fracture risk prediction in postmenopausal women.

Entities:  

Keywords:  Bone mineral density; Executive functions; Fracture risk; Osteoporosis; Postmenopausal

Year:  2019        PMID: 31773488     DOI: 10.1007/s40520-019-01426-w

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  6 in total

Review 1.  The association between hypoparathyroidism and cognitive impairment: a systematic review.

Authors:  A Sardella; F Bellone; N Morabito; S Minisola; G Basile; F Corica; A Catalano
Journal:  J Endocrinol Invest       Date:  2020-09-14       Impact factor: 4.256

2.  Utility of fragility fracture prediction tools in a group of postmenopausal women.

Authors:  Jarosław Amarowicz; Agnieszka Krawczyk; Anna Kumorek
Journal:  Reumatologia       Date:  2021-08-20

3.  Editorial: Psychological Factors as Determinants of Medical Conditions, Volume II.

Authors:  Andrea Caputo; Carmelo Mario Vicario; Valentina Cazzato; Gabriella Martino
Journal:  Front Psychol       Date:  2022-03-21

4.  Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer.

Authors:  Gabriella Martino; Antonino Catalano; Rita Maria Agostino; Federica Bellone; Nunziata Morabito; Carmen Giulia Lasco; Carmelo Mario Vicario; Peter Schwarz; Ulla Feldt-Rasmussen
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

5.  Going Beyond the Visible in Type 2 Diabetes Mellitus: Defense Mechanisms and Their Associations With Depression and Health-Related Quality of Life.

Authors:  Gabriella Martino; Andrea Caputo; Federica Bellone; Maria C Quattropani; Carmelo M Vicario
Journal:  Front Psychol       Date:  2020-02-26

6.  Bone Mineral Density Measurements and Association With Brain Structure and Cognitive Function: The Framingham Offspring Cohort.

Authors:  Maria Stefanidou; Adrienne O'Donnell; Jayandra J Himali; Charles DeCarli; Claudia Satizabal; Alexa S Beiser; Sudha Seshadri
Journal:  Alzheimer Dis Assoc Disord       Date:  2021 Oct-Dec 01       Impact factor: 2.703

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.